Menu
Not yet recruiting NCT06906055

Below-the-Knee Interventions for Limb Salvage: Use of Multifunctional Angioplasty Balloon Catheters

No phase Interventional Peripheral Arterial Disease Below the Knee Peripheral Arterial Disease, Rutherford 4 and 5 with Possibility to Improve Vascularization

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Multicath, Standard of Care (SOC).
Who it may be relevant to
Registry conditions: Peripheral Arterial Disease Below the Knee, Peripheral Arterial Disease, Rutherford 4 and 5 with Possibility to Improve Vascularization. Basic parameters: 18 years — 120 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Below-the-Knee Interventions for Limb Salvage: Use of Multifunctional Angioplasty Balloon Catheters ("BTK Multicath Registry") A non-randomized clinical registry This study is designed to obtain preliminary data on clinically relevant procedural variables during percutaneous below-knee artery revascularization procedures among consecutive patients treated with either the Finesse BTK Multicath® ("Finesse") or the standard of care using conventional angioplasty balloon catheters. This registry will enroll participants with a history of chronic limb threatening ischemia and below-knee arterial insufficiency who will be assigned to revascularization with or without use of the Finesse BTK Multicath. The registry is an acute study examining procedural data only. The primary endpoints of interest are the volume of contrast used for the intervention, overall procedure time, radiation dose, number of catheter exchanges during revascularization, and medical device supply costs. For the first phase 12 consecutive patients will be treated with the standard of care. For the second phase 12 consecutive patients will be treated with Finesse. 24 participants total Up to 5 study sites in the United States Initial anticipated enrollment: Q4 2024 Last anticipated enrollment: Q2 2025 Patients \>=18 years old with documented history of unilateral chronic limb threatening ischemia due to below-knee arterial insufficiency with angiographic runoff in the foot and limited arterial insufficiency above the knee 1. Contrast volume administered during the revascularization portion of a procedure. 2. Number of catheter exchanges during revascularization 3. Fluoroscopy time 4. Radiation dose during revascularization 5. Procedure time post-enrollment 6. Equipment costs 7. Reduced use of supplies 8. Technical success 9. Safety/Major Adverse Peripheral Events On-treatment sample Intention-to-treat

Interventions

  • Device Multicath
    Use of a multifunctional catheter for revascularization of blocked arteries below the knee
  • Device Standard of Care (SOC)
    Use of single function crossing catheters, diagnostic catheters, angioplasty balloon catheters

Primary outcome measures

  • Contrast volume [Time frame: during the intervention/procedure/surgery]

Eligibility criteria

Inclusion criteria

  • Participant must provide written informed consent prior to any clinical investigation-related procedures.
  • Age ≥ 18 years
  • Planned lower extremity catheter-based revascularization for Rutherford 4 through 6 chronic limb-threatening ischemia (Table 1)
  • Stenotic (>=70% stenosis by visual estimate) or occlusive lesion in an infrapopliteal artery (anterior tibial, peroneal, or posterior tibial) by angiography
  • Target lesion up to 25cm in length by angiography

Exclusion criteria

  • Participation in another clinical investigation that has not yet completed its primary end point.
  • Incapacitated individuals, defined as persons who are mentally ill, mentally handicapped, or individuals without legal authority, are excluded from the study population.
  • Female subjects of childbearing potential unless negative pregnancy test or contraceptive use
  • Bilateral critical limb ischemia
  • Planned bilateral vascular intervention
  • Lack of reconstitution of foot runoff vessels at ankle joint
  • Planned below-the-ankle intervention after completion of diagnostic angiography
  • Planned suprainguinal intervention ->=5cm with at least 50% stenosis of the above knee femoro-popliteal artery

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Non-randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

United States · 2 centers
  • Endovascular Consultants — Wilmington
  • Atlantic Medical Imaging — Vineland

Identifiers

NCT: NCT06906055 · CT-0119-01

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗